. Fit of model A2 to the data with dead individuals included. When dead individuals are included, this model fits poorly to the data from the low dose treatment. Also, it predicts the same peak titer for all three doses. Figure S3 . Fit of model B1 to the data with dead individuals included. This model predicts the same peak titer for all three doses. It also predicts damped oscillations towards a stable equilibrium, which is why the predicted titer is rising at the end. This doesn't seem biologically realistic, but we don't have enough long-term data to fully test this prediction. In any case, the model does not have the best fit, because of its poor fit to the data from the low dose treatment. Figure S4 . Fit of model B3 to the data with dead individuals included. This model is different from B2, because it assumes a logistic growth of the viral population (i.e., carrying capacity). However, it is clear that this model is over-fit, because it gives nearly identical predictions as model B2, but with an added parameter. Basically, the addition of the viral carrying capacity does not affect the predicted dynamics, and so the model is not parsimonious. Figure S8 . Fit of model B3 to the data with no dead individuals. This model is different from B2, because it assumes a logistic growth of the viral population (i.e., carrying capacity). However, it is clear that this model is over-fit, because it gives nearly identical predictions as model B2, but with an added parameter. Basically, the addition of the viral carrying capacity does not affect the predicted dynamics, and so the model is not parsimonious. Figure S11. Fit of model B1 to the data with no dead individuals. This model struggled to converge, leading to multiple potential outcomes, as can be seen in the 95% credible interval of the model fit. This model also fits poorly to the high dose data, as it predicts the same peak titer for all doses. 
IV. Alternative model fits -without dead individuals

